IL6 and neoplasm: Finally, in terms of tumor access, IL-6 has been described as the key glioblastoma-derived factor that promotes anti-inflammatory and wound-healing type responses, inducing strategic tissue remodeling to prevent immunologic access to the tumor by T cells [43].